Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.

To improve stratification of risk-adapted treatment for non-metastatic (M0), standard-risk medulloblastoma patients by prospective evaluation of biomarkers of reported biological or prognostic significance, alongside clinico-pathological variables, within the multi-center HIT-SIOP-PNET4 trial.

Lannering, Birgitta,1948Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics(Swepub:gu)xlabir (author)
Schwalbe, Ed C (author)
Hicks, Debbie (author)
Toole, Kieran O' (author)
Nicholson, Sarah Leigh (author)
Goschzik, Tobias (author)
Zur Mühlen, Anja (author)
Figarella-Branger, Dominique (author)
Doz, François (author)
Rutkowski, Stefan (author)
Gustafsson, Göran (author)
Pietsch, Torsten (author)
Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för pediatrik (creator_code:org_t)

By the author/editor: Clifford, Steven ...; Lannering, Birgi ...; Schwalbe, Ed C; Hicks, Debbie; Toole, Kieran O'; Nicholson, Sarah ...; show more...; Goschzik, Tobias; Zur Mühlen, Anja; Figarella-Brange ...; Doz, François; Rutkowski, Stefa ...; Gustafsson, Göra ...; Pietsch, Torsten; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Pediatrics

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.